Moscow Exchange · APTK · IFRS
36.6 Pharmacy Chain: revenue, profit and cash flow
In 2025, 36.6 Pharmacy Chain had revenue of ₽106B and a net profit of ₽263M, according to its consolidated IFRS statements. Here: 13 years of annual reports since 2012, each linked to the original document.
Revenue, 2025
change against 2024
Where the money goes
Of every ₽100 of revenue in 2025, 36.6 Pharmacy Chain spent ₽66.9 on the cost of its products and services and ₽32.6 on running the business; ₽0.2 went to income tax, and ₽0.2 was left as net profit.
| In 2025 | Amount | Of revenue |
|---|---|---|
| Revenue | ₽106B | 100.0% |
| Cost of revenue | −₽70.7B | 66.9% |
| Gross profit | ₽35B | 33.1% |
| Operating expenses | −₽34.5B | 32.6% |
| Profit before tax | ₽491M | 0.5% |
| Income tax | −₽228M | 0.2% |
| Net profit | ₽263M | 0.2% |
In 2025, 36.6 Pharmacy Chain took in ₽5.07B of cash from its operations. Of every ₽100 of it, it spent ₽19.6 on capital expenditure and ₽2.2 on buying other companies. The remaining ₽78.2 was left for other uses: repaying debt, investments or the cash balance.
| In 2025 | Amount | Of operating cash |
|---|---|---|
| Operating cash flow | ₽5.07B | 100.0% |
| Capital expenditure | −₽993M | 19.6% |
| Free cash flow | ₽4.08B | 80.4% |
| Acquisitions | −₽113M | 2.2% |
| Left over | ₽3.96B | 78.2% |
Revenue and net profit
Revenue went from ₽14.9B in 2012 to ₽106B in 2025. Net loss in 2012–2013, 2015–2018, 2021.
Earnings per share
Basic earnings per share went from −₽9.20 in 2016 to ₽0.04 in 2025. Years before 2016 are left out: the number of shares changed that year, and the reports do not restate the earlier figures to the new count.
Number of shares
The weighted average number of ordinary shares went from 936M in 2015 to 7.51B in 2025.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was ₽4.08B in 2025, 3.9% of revenue. Negative in 2013–2014, 2016–2018, 2020.
What it owns and who paid for it
At the end of 2025, 36.6 Pharmacy Chain had ₽64.1B of assets, ₽1.36B of it in cash, but its liabilities came to ₽71.4B, ₽7.3B more than everything it owns: its shareholders' equity is negative.
Net debt
Net debt (borrowings minus cash) was ₽21.8B at the end of 2025.
The charts could not be loaded; the table below has the same numbers.
36.6 Pharmacy Chain: annual figures
| Year | Revenue | Operating profit | Net profit | Basic EPS | Operating cash flow | Capital expenditure | Free cash flow | Net debt | Dividends paid | Total assets | Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₽106B | — | ₽263M | ₽0.04 | ₽5.07B | ₽993M | ₽4.08B | ₽21.8B | — | ₽64.1B | −₽7.3B |
| 2024 | ₽87.2B | — | ₽267M | ₽0.04 | ₽6.49B | ₽721M | ₽5.77B | ₽21.2B | — | ₽60.8B | −₽7.56B |
| 2023* | ₽67.4B | — | ₽120M | ₽0.02 | ₽7.05B | ₽649M | ₽6.4B | ₽18.6B | — | ₽53.2B | −₽6.83B |
| 2022 | ₽59B | — | ₽223M | ₽0.03 | ₽6.59B | ₽694M | ₽5.9B | ₽18.1B | — | ₽43.6B | −₽6.43B |
| 2021 | ₽44.1B | — | −₽950M | −₽0.10 | ₽3.23B | ₽699M | ₽2.53B | ₽19.9B | — | ₽37.8B | −₽6.65B |
| 2020* | ₽39.3B | — | ₽6.35B | ₽0.90 | −₽3.37B | ₽1.69B | −₽5.06B | ₽39.1B | — | ₽54.4B | −₽5.7B |
| 2018 | ₽44.7B | — | −₽23B | −₽9.90 | −₽9.2B | ₽645M | −₽9.84B | ₽45.4B | — | ₽32.7B | −₽36.8B |
| 2017 | ₽48.3B | — | −₽13.1B | −₽5.60 | −₽11.1B | ₽365M | −₽11.5B | ₽31.5B | ₽0 | ₽39.9B | −₽13.8B |
| 2016 | ₽45.9B | — | −₽9.35B | −₽9.20 | −₽3.48B | ₽381M | −₽3.86B | ₽19.7B | ₽0 | ₽44.8B | −₽531M |
| 2015* | ₽31.9B | — | −₽178M | — | ₽3.81B | ₽178M | ₽3.63B | ₽12.9B | ₽0 | ₽27.3B | ₽1.39B |
| 2014 | ₽6.88B | ₽1.45B | ₽905M | — | −₽459M | ₽75M | −₽534M | ₽10.7B | ₽0 | ₽16.9B | −₽10.1B |
| 2013* | ₽11.9B | −₽7.81B | −₽10.4B | — | −₽4.79B | ₽38M | −₽4.83B | ₽7.68B | ₽0 | ₽3.8B | −₽10.7B |
| 2012* | ₽14.9B | ₽878M | −₽971M | — | ₽924M | ₽124M | ₽800M | ₽8.91B | ₽0 | ₽22.2B | ₽214M |
* Taken from the comparative column of the next year's report: the year's own report was not available to us.
Original reports
Every figure on this page comes from the company's own annual statements. The documents, by year:
- 2025 — IFRS consolidated financial statements
- 2024 — IFRS consolidated financial statements
- 2022 — IFRS consolidated financial statements
- 2021 — IFRS consolidated financial statements
- 2018 — IFRS consolidated financial statements
- 2017 — IFRS consolidated financial statements
- 2016 — IFRS consolidated financial statements
- 2014 — IFRS consolidated financial statements
- 2013 — IFRS consolidated financial statements
How to read these numbers
- A year's figures are as first reported. Companies sometimes restate the previous year in their next report (new accounting standards, discontinued operations); the original documents show both versions.
Source: annual financial statements published by 36.6 Pharmacy Chain (links to the original documents above). Figures read from the documents by BigCapital.
For information only, not investment advice.